Drag a card by its title · ⚙ to size, swap or remove

The company

eXoZymes Inc.

EXOZ · Nasdaq

Health CareBiotechnologyNot moving yet

EXOZ stood above a rising 150-day average in 6 of the last 52 weekly readings, and has been out of that trend for the last 43 weeks. It is 47.6% below that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−9 points in four weeks); Health Care: 28% (−6 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 43
Industry in uptrend: 18% -9 in 4 wk
Insider buys, 12 months: $13K
Insider sales, 12 months: $31K
Officials’ trades on record: 0
Institutions holding: 10 (+3)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 6 of 52 weeks.

23 Apr – 22 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months2

Sale orders, 12 months2

Buyers · sellers1 · 1

Who	Did	Shares	Traded
Michael HeltzenChief Executive Officer	bought	4at $7.58	26 Aug 2026filed 2 Sep 2026
Michael HeltzenChief Executive Officer	bought	251at $7.35	26 Aug 2026filed 2 Sep 2026
Michael HeltzenChief Executive Officer	bought	250at $7.60	26 Aug 2026filed 2 Sep 2026
Michael HeltzenChief Executive Officer	bought	250at $7.52	25 Aug 2026filed 2 Sep 2026
Michael HeltzenChief Executive Officer	bought	100at $7.50	25 Aug 2026filed 2 Sep 2026
Tyler Paz KormanChief Scientific Officer	sold	750at $10.53	9 Apr 2026filed 10 Apr 2026
Tyler Paz KormanChief Scientific Officer	sold	750at $10.04	8 Apr 2026filed 10 Apr 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders10+3 on the quarter

New · exited3 · 0

Reported value$1.0M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	54,985$464K	+32,795+147.8%
Davidson Kahn Capital Management, LLCnew · filed 15 Jul 2026	25,000$211K	+25,000
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026	23,406$197K	+1,515+6.9%
BlackRock, Inc.added · filed 7 Aug 2026	9,610$81K	+2,813+41.4%
VANGUARD FIDUCIARY TRUST COunchanged · filed 13 Aug 2026	9,426$79K	00.0%
MORGAN STANLEYunchanged · filed 13 Aug 2026	1,250$11K	00.0%
Tower Research Capital LLC (TRC)reduced · filed 11 Aug 2026	349$2,942	-968−73.5%
MERCER GLOBAL ADVISORS INCnew · filed 11 Aug 2026	250$2,108	+250
UBS Group AGadded · filed 13 Aug 2026	203$1,711	+179+745.8%
BARCLAYS PLCnew · filed 14 Aug 2026	75$632	+75